Literature DB >> 543515

Clinical and laboratory diagnosis of hemostatic disorders in newborn infants.

A Zipursky, D deSa, E Hsu, M Johnston, R Milner.   

Abstract

We describe a microtechnology for the study of the coagulation system in newborn infants. Interpretation of results demands an understanding of the techniques used and the nature of the control population from which normal values are drawn. We have examined two syndromes which represent the majority of hemostatic disorders of sick newborn infants. The first is thrombocytopenia resulting from bacterial infections in which there are minimal changes in the levels of blood coagulation factors and little tendency to bleed. The second is a syndrome of disseminated intravascular coagulation in which there is a profound disturbance in the coagulation mechanism, relatively little change in platelet counts, a severe hemorrhagic diathesis, and widespread ischemic necrosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 543515     DOI: 10.1097/00043426-197923000-00005

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  3 in total

1.  Low antithrombin III in neonatal shock: DIC or non-specific protein depletion?

Authors:  B K Schmidt; T Muraji; A Zipursky
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

2.  Plasma elimination of antithrombin III (heparin cofactor activity) is accelerated in term newborn infants.

Authors:  B Schmidt; U Wais; W Pringsheim; W Künzer
Journal:  Eur J Pediatr       Date:  1984-02       Impact factor: 3.183

Review 3.  Hematologic and oncologic complications in the critically ill child.

Authors:  S McIntosh
Journal:  Yale J Biol Med       Date:  1984 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.